Back to Sites

Kilimanjaro Christian Medical Centre (KCMC)

Site Number

5118

Address

Kilimanjaro Christian Medical CRS
Kilimanjaro Christian Medical Center
KCMC-Duke Collaboration
P.O. Box 3010
Sokoine Road
Moshi,
Tanzania

IMPAACT Members at this Site

Emanueli Msuya CAB Representative

Levina January Msuya Co-Investigator

Werner Schimana Co-Investigator

Suzanne Fiorillo CRS Coordinator

Boniface Njau CRS Coordinator

John A. Crump CRS Leader

Blandina Mmbaga CRS Leader

Elizabeth Reddy CRS Leader

Fortunata Nasuwa CRS Staff

Eileen Pouliot DAIDS PO

Portina Zongollo Data Clerk

Alphonce S. Mushi Data Manager

Evaline Ndosi Data Manager

James Ngocho Investigator

Shanette Nixon Laboratory Manager/Supervisor

Michael Omondi Laboratory Manager/Supervisor

Augustine Musyoka Laboratory Technician

Seleman Khamis Semvua Pharmacist of Record

Grace Kinabo Principal Investigator

Rahma Musoke Quality Assurance

Ruth S. Laizer Regulatory Coordinator

Severa Edgar Luhanga Regulatory Coordinator

Euphrasia Mariki Research Nurse

Oliver Matemu Research Nurse

Winfrida Nkoroi Research Nurse

Twilumba Mgohamwende Study Coordinator

Winfrida Shirima Study Coordinator

Studies at this Site

P1026S: PK in Pregnancy

DAIDS Number

Therapeutics

Research Area

Treatment

Study Status

Closed to Follow Up

P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT

DAIDS Number

10166

Research Area

Treatment

Study Status

Concluded

P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers

DAIDS Number

10638

Research Area

Complications & Comorbidities

Study Status

Concluded

P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age

DAIDS Number

10655

Research Area

Other

Study Status

Concluded

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

10732

Research Area

Tuberculosis

Study Status

Participants Off Study and Primary Analysis Completed

P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children

DAIDS Number

11689

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1097: Raltegravir PK Study

DAIDS Number

11790

Research Area

Treatment

Study Status

Concluded

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling